Tumor Size Remains Key for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation
β Scribed by T. M. Earl; W. C. Chapman
- Book ID
- 111774075
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 128 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1068-9265
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To confirm recent observations about the relationship between immunosuppression and the recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT), we retrospectively analyzed 70 consecutive HCC patients who underwent LT and received cyclosporine (CsA) -based immunosuppression. Cs
## Background Long-term survival of patients with hepatocellular carcinoma (HCC) after liver transplantation is affected mainly by recurrence of HCC. There is the opinion that the chance of recurrence after 2Β years post-transplantation is remote, and therefore lifelong surveillance is not justified